Early detection of bowel and breast cancer greatly increase survival rates. However, participation rates in Australia’s national bowel and breast cancer screening programs are low. In addition, Australia’s screening programs are population-based and mostly do not target patients considered to be at higher risk.

This scorecard rates the pace of change in Australia against the seven recommendations of the 2021 CGT: Rising to the challenge white paper, with 16 expert informed and endorsed indicators.

This white paper analyses the current state of chimeric antigen receptor (CAR) T-cell therapy in Australia, expected opportunities and our healthcare system’s preparedness for delivering CAR T-cell therapy at scale.

This report is the third national report to present key data specific to cancer in adolescents and young adults (aged 15–24 years) in Australia. While cancer in young Australians is rare, it has a substantial social and economic impact on individuals, families and communities. Surveillance of this population is also important as adolescent and young...

This report presents the latest available information on the incidence of mesothelioma in Australia, along with mortality, survival and asbestos exposure information, using data from the Australian Mesothelioma Registry, the National Mortality Database and the Australian Cancer Database.